{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T06:42:58Z","timestamp":1722753778903},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41443-018-0076-9","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T15:38:09Z","timestamp":1537976289000},"page":"57-60","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra\u2019s advent. A personal perspective"],"prefix":"10.1038","volume":"31","author":[{"given":"N. F.","family":"Gonzalez-Cadavid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rajfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1056\/NEJM199201093260203","volume":"326","author":"J Rajfer","year":"1992","unstructured":"Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neuro-transmission. N Engl J Med. 1992;326:90\u20134.","journal-title":"N Engl J Med"},{"key":"76_CR2","first-page":"51","volume":"3","author":"NF Gonzalez-Cadavid","year":"1999","unstructured":"Gonzalez-Cadavid NF, Ignarro LJ, Rajfer J. Nitric oxide and the cyclic GMP system in the penis. Mol Urol. 1999;3:51\u20139.","journal-title":"Mol Urol"},{"key":"76_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","volume":"7","author":"D Vernet","year":"2002","unstructured":"Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, et al. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie\u2019s fibrotic plaque and in its rat model. Nitric Oxide. 2002;7:262\u201376.","journal-title":"Nitric Oxide"},{"key":"76_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","volume":"9","author":"EG Valente","year":"2003","unstructured":"Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie\u2019s fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9:229\u201344.","journal-title":"Nitric Oxide"},{"key":"76_CR5","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1095\/biolreprod.104.030833","volume":"71","author":"HH Davila","year":"2004","unstructured":"Davila HH, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie\u2019s disease. Biol Reprod. 2004;71:1568\u201377.","journal-title":"Biol Reprod"},{"key":"76_CR6","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.2174\/138161205774913372","volume":"11","author":"NF Gonzalez-Cadavid","year":"2005","unstructured":"Gonzalez-Cadavid NF, Rajfer J. The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. Curr Pharm Des. 2005;11:4041\u20136.","journal-title":"Curr Pharm Des"},{"key":"76_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","volume":"97","author":"MG Ferrini","year":"2006","unstructured":"Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie\u2019s disease. BJU Int. 2006;97:625\u201333.","journal-title":"BJU Int"},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ncpuro0201","volume":"2","author":"NF Gonzalez-Cadavid","year":"2005","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie\u2019s disease. Nat Clin Pract Urol. 2005;2:291\u20137.","journal-title":"Nat Clin Pract Urol"},{"key":"76_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1743-6109.2008.01104.x","volume":"6","author":"NF Gonzalez-Cadavid","year":"2009","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Experimental models of Peyronie\u2019s disease. Implications for new therapies. J Sex Med. 2009;6:303\u201313.","journal-title":"J Sex Med"},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrurol.2010.24","volume":"7","author":"NF Gonzalez-Cadavid","year":"2010","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie\u2019s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010;7:215\u201321.","journal-title":"Nat Rev Urol"},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","volume":"7","author":"D Ralph","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, et al. The management of Peyronie\u2019s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7:2359\u201374.","journal-title":"J Sex Med"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1743-6109.2008.01105.x","volume":"6","author":"MG Ferrini","year":"2009","unstructured":"Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med. 2009;6:415\u201328.","journal-title":"J Sex Med"},{"key":"76_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.urology.2006.05.011","volume":"68","author":"MG Ferrini","year":"2006","unstructured":"Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology. 2006;68:429\u201335.","journal-title":"Urology"},{"key":"76_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1095\/biolreprod.106.059642","volume":"76","author":"MG Ferrini","year":"2007","unstructured":"Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, et al. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod. 2007;76:915\u201323.","journal-title":"Biol Reprod"},{"key":"76_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.ijir.3901612","volume":"20","author":"I Kovanecz","year":"2008","unstructured":"Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, et al. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008;20:202\u201312.","journal-title":"Int J Impot Res"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","volume":"101","author":"I Kovanecz","year":"2008","unstructured":"Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008;101:203\u201310.","journal-title":"BJU Int"},{"key":"76_CR17","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/j.1743-6109.2012.02913.x","volume":"9","author":"I Kovanecz","year":"2012","unstructured":"Kovanecz I, Rivera S, Nolazco G, Vernet D, Segura D, Gharib S, et al. Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. J Sex Med. 2012;9:2814\u201326.","journal-title":"J Sex Med"},{"issue":"Suppl 3","key":"76_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1743-6109.2008.01195.x","volume":"6","author":"NF Gonzalez-Cadavid","year":"2009","unstructured":"Gonzalez-Cadavid NF. Mechanisms of penile fibrosis. J Sex Med. 2009;6(Suppl 3):353\u201362.","journal-title":"J Sex Med"},{"key":"76_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1743-6109.2005.20103.x","volume":"2","author":"I S\u00e1enz de Tejada","year":"2005","unstructured":"S\u00e1enz de Tejada I, Angulo J, Cellek S, Gonz\u00e1lez-Cadavid N, Heaton J, Pickard R. Simonsen U pathophysiology of erectile dysfunction. J Sex Med. 2005;2:26\u201339.","journal-title":"J Sex Med"},{"key":"76_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.ijir.3901588","volume":"20","author":"A Rambhatla","year":"2008","unstructured":"Rambhatla A, Kovanecz I, Ferrini M, Gonzalez-Cadavid NF, Rajfer J. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. Int J Impot Res. 2008;20:30\u20134.","journal-title":"Int J Impot Res"},{"key":"76_CR21","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/S0022-5347(05)67616-1","volume":"163","author":"TJ Bivalacqua","year":"2000","unstructured":"Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, et al. A rat model of Peyronie\u2019s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol. 2000;163:1992\u20138.","journal-title":"J Urol"},{"key":"76_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11934-013-0342-9","volume":"14","author":"KC Lee","year":"2013","unstructured":"Lee KC, Brock GB. Daily dosing of PDE5 inhibitors: where does it fit in? Curr Urol Rep. 2013;14:269\u201378.","journal-title":"Curr Urol Rep"},{"key":"76_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.aju.2013.05.004","volume":"11","author":"PH Egydio","year":"2013","unstructured":"Egydio PH, Kuehhas FE. Treatments for fibrosis of the corpora cavernosa. Arab J Urol. 2013;11:294\u20138.","journal-title":"Arab J Urol"},{"key":"76_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2164\/jandrol.107.003483","volume":"29","author":"AL Burnett","year":"2008","unstructured":"Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl. 2008;29:3\u201314.","journal-title":"J Androl"},{"key":"76_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11926-016-0597-5.","volume":"18","author":"VK Jaeger","year":"2016","unstructured":"Jaeger VK, Walker UA. Erectile dysfunction in systemic sclerosis. Curr Rheumatol Rep. 2016;18:49 https:\/\/doi.org\/10.1007\/s11926-016-0597-5","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 1","key":"76_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-12-S1-S24","volume":"12","author":"F Iacono","year":"2012","unstructured":"Iacono F, Prezioso D, Ruffo A, Illiano E, Romis L, Di Lauro G, et al. Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among age, TDS and ED. BMC Surg. 2012;12(Suppl 1):S24.","journal-title":"BMC Surg"},{"key":"76_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1517\/13543784.2011.609315","volume":"20","author":"AI El-Sakka","year":"2011","unstructured":"El-Sakka AI. Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors. Expert Opin Investig Drugs. 2011;20:1305\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"76_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/jsm.12478","volume":"11","author":"L Vignozzi","year":"2014","unstructured":"Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Maneschi E, et al. Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. J Sex Med. 2014;11:1159\u201372.","journal-title":"J Sex Med"},{"key":"76_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsxm.2015.12.001","volume":"13","author":"JI Mart\u00ednez-Salamanca","year":"2016","unstructured":"Mart\u00ednez-Salamanca JI, Zurita M, Costa C, Mart\u00ednez-Salamanca E, Fern\u00e1ndez A, Castela A, et al. Dual strategy with oral phosphodiesterase type 5 inhibition and intracavernosal implantation of mesenchymal stem cells is superior to individual approaches in the recovery of erectile and cavernosal functions after cavernous nerve injury in rats. J Sex Med. 2016;13:1\u201311.","journal-title":"J Sex Med"},{"key":"76_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-159.","volume":"10","author":"JS Wang","year":"2012","unstructured":"Wang JS, Kovanecz I, Vernet D, Nolazco G, Kopchok GE, Chow SL, et al. Effects of sildenafil and\/or muscle derived stem cells on myocardial infarction. J Transl Med. 2012;10:159 https:\/\/doi.org\/10.1186\/1479-5876-10-159","journal-title":"J Transl Med"},{"key":"76_CR31","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1111\/j.1743-6109.2010.01884.x","volume":"7","author":"MG Ferrini","year":"2010","unstructured":"Ferrini MG, Rivera S, Moon J, Vernet D, Rajfer J, Gonzalez-Cadavid NF. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes. J Sex Med. 2010;7:3033\u201344.","journal-title":"J Sex Med"},{"key":"76_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.cardiores.2003.12.006","volume":"61","author":"MG Ferrini","year":"2004","unstructured":"Ferrini MG, Davila HH, Valente EG, Gonzalez-Cadavid NF, Rajfer J. Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media. Cardiovasc Res. 2004;61:796\u2013805.","journal-title":"Cardiovasc Res"},{"issue":"4 Suppl","key":"76_CR33","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.fertnstert.2006.01.058","volume":"86","author":"MG Ferrini","year":"2006","unstructured":"Ferrini MG, Nolazco G, Vernet D, Gonzalez-Cadavid NF, Berman J. Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis. Fertil Steril. 2006;86(4 Suppl):1152\u201363.","journal-title":"Fertil Steril"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0076-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0076-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T20:00:19Z","timestamp":1720641619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0076-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0076-9","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Gonzalez-Cadavid and Dr. Rajfer have a financial interest in a related U.S. Patent and its continuation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}